Search results
Results From The WOW.Com Content Network
If a BSO is combined with an abdominal hysterectomy (there are different methods of hysterectomy available), the procedure is commonly called a TAH-BSO: Total Abdominal Hysterectomy with a Bilateral Salpingo-Oophorectomy. Sexual intercourse remains possible after salpingectomy, surgical and radiological cancer treatments, and chemotherapy.
Hysterectomy is the surgical removal of the uterus and cervix. Supracervical hysterectomy refers to removal of the uterus while the cervix is spared. These procedures may also involve removal of the ovaries ( oophorectomy ), fallopian tubes ( salpingectomy ), and other surrounding structures. The term “partial” or “total” hysterectomy ...
The formal medical name for removal of a woman's entire reproductive system (ovaries, fallopian tubes, uterus) is "total abdominal hysterectomy with bilateral salpingo-oophorectomy" (TAH-BSO); the more casual term for such a surgery is "ovariohysterectomy". "Hysterectomy" is removal of the uterus (from the Greek ὑστέρα hystera "womb" and ...
The first radical hysterectomy operation was described by John G. Clark, resident gynecologist under Howard Kelly at the Johns Hopkins Hospital in 1895. In 1898, Ernst Wertheim, a Viennese physician, developed the radical total hysterectomy with removal of the pelvic lymph nodes and the parametrium. In 1905, he reported the outcomes of his ...
Hysterectomy and bilateral salpingo-oophorectomy. Hysterectomy is a surgical procedure performed to remove the uterus. A total hysterectomy involves removal of the uterus and cervix, and a sub-partial hysterectomy involves removal of only the uterus. Bilateral salpingo-oophorectomy (BSO) is the removal of both ovaries and fallopian tubes.
The most common treatment modality for endometrial cancer is surgery, whereby the uterus is removed via a total hysterectomy. Hysterectomies may also be accompanied by removal of ovaries and fallopian tubes, called a salpingo-oophorectomy. Additionally, hormone therapy which seeks to block the growth of cancer cells may also be used in the ...
Uterine serous carcinoma is a malignant form of serous tumor that originates in the uterus. It is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is typically diagnosed on endometrial biopsy, prompted by post-menopausal bleeding . Unlike the more common low-grade endometrioid endometrial adenocarcinoma ...
Borderline ovarian tumours (BOTs) have been qualified as low malignant potential tumours by the FIGO since 1971. They are classified within malignant epithelial ovarian tumours, constituting 10–20% of these. [4] Their incidence is low, and is calculated in European series at around 4.8/100,000 new cases per year and even lower in American ...